Preemption Remains Conference Issue In FDA Bill As Both Sides Declare Victory
Executive Summary
The impact of FDA reform legislation on product liability lawsuits could depend in large part on how the House and Senate resolve subtle differences in phrasing between the two chambers' bills
You may also be interested in...
Pre-emption Limits Survive In Congress, Must Now Stare Down Supreme Court
After enactment of the FDA Revitalization Act, the next challenge for trial lawyers and their allies is to see that the hard-won language on pre-emption of lawsuits is used effectively in court
Discounted “Stopgap” PDUFA Renewal Might Prompt Faster FDARA Action
A proposal circulated by House Democrats to renew user fee programs for three months while negotiations on FDA reform legislation continue is "not an option," Senate Health, Education, Labor and Pensions Committee Ranking Republican Michael Enzi, Wyo., has declared
Discounted “Stopgap” PDUFA Renewal Might Prompt Faster FDARA Action
A proposal circulated by House Democrats to renew user fee programs for three months while negotiations on FDA reform legislation continue is "not an option," Senate Health, Education, Labor and Pensions Committee Ranking Republican Michael Enzi, Wyo., has declared